Common Side Reactions in SPPS | Alan Scientific
Understand common side reactions in solid-phase peptide synthesis, including aggregation, incomplete coupling, deletion sequences, racemization and aspartimide formation, with practical approaches for difficult peptide synthesis.
Solid-phase peptide synthesis (SPPS) is often described as a repetitive cycle of Fmoc deprotection and amino acid coupling. In practice, however, the chemical environment of a resin-bound peptide changes continuously as the chain grows. A sequence that behaves normally during its early cycles may later become difficult because of aggregation, reduced reagent accessibility, incomplete coupling, inefficient deprotection, or sequence-specific side reactions.
For difficult peptides, the central question is therefore not simply whether a coupling reagent is sufficiently reactive. It is whether the growing peptide remains chemically accessible and structurally manageable throughout the synthesis.
Why Peptide Aggregation Matters in SPPS
Aggregation of resin-bound peptide chains is one of the major causes of difficult solid-phase synthesis. Hydrogen bonding, hydrophobic interactions and local secondary structure can bring neighboring peptide chains into close association. As aggregation develops, resin swelling and reagent diffusion may decrease, making some reactive sites less accessible to activated amino acids or deprotection reagents.
This explains why peptide length alone is not a reliable measure of synthesis difficulty. A relatively long but well-solvated sequence may assemble efficiently, while a much shorter hydrophobic or aggregation-prone peptide can become problematic early in chain elongation. Resin loading, solvent environment, amino acid composition and protecting-group strategy can all influence this behavior.

Incomplete Coupling and Deletion Sequences
Incomplete coupling becomes particularly important because SPPS is an iterative process. If an amino acid is incorporated into only part of the resin-bound peptide population, the unreacted chains may continue through subsequent synthesis cycles. The final crude product can therefore contain peptides that are nearly identical to the desired sequence but lack one or more residues.
These deletion sequences may be difficult to remove because their charge, molecular size and hydrophobicity can remain similar to those of the target peptide. A relatively small synthesis problem can therefore become a much more difficult purification problem later.
This is an important practical consideration in peptide manufacturing: final HPLC purification cannot always compensate efficiently for poor chain assembly. Improving crude peptide quality during synthesis can reduce purification complexity, solvent consumption and loss of target material during fraction collection.
Racemization and Aspartimide Formation
Not every SPPS impurity results from incomplete reactions. Some arise from chemical changes to residues that have already been incorporated correctly.
Racemization may occur during amino acid activation, generating an epimer with the same molecular formula and nominal molecular weight as the desired product. Residues such as cysteine and histidine can require particular attention depending on activation chemistry and reaction conditions. Because an epimerized peptide may have the same molecular mass as the target, mass spectrometry alone may not always reveal the problem.
Aspartimide formation is another important sequence-dependent reaction. Under basic Fmoc-deprotection conditions, susceptible Asp-containing sequences can form a cyclic succinimide intermediate. Subsequent ring opening may produce several closely related products, including α- and β-linked species and potentially epimerized impurities.
For this reason, stronger activation, longer reaction times or higher temperature should not automatically be considered better conditions. Improving one difficult coupling can sometimes increase a different chemical liability elsewhere in the sequence.
How to Recognize a Difficult Synthesis
Troubleshooting is more effective when attention is focused on where peptide behavior begins to change rather than treating every synthesis cycle identically.
| Observed Problem | Possible Interpretation |
| Sudden reduction in coupling efficiency | Local aggregation or reduced resin accessibility |
| Peptide lacking one specific residue | Incomplete coupling or incomplete deprotection |
| Similar mass with multiple HPLC peaks | Possible epimerization or closely related structural isomers |
| Multiple Asp-related impurities | Possible aspartimide chemistry |
| Highly complex crude HPLC profile | Accumulation of several synthesis-related impurities |
Literature Case Study: Pediocin PA-1
A useful example is the chemical synthesis of pediocin PA-1, a 44-residue antimicrobial peptide containing two disulfide bonds. In a published study, the first attempt to prepare its linear precursor by standard stepwise Fmoc-SPPS produced a complex mixture of shorter peptides rather than the desired full-length product.
The researchers did not simply increase coupling time throughout the synthesis. Instead, C-terminal ladder sequences were prepared and analyzed by LC-MS to identify where chain assembly was failing. The analysis showed that incorporation of Fmoc-Asn(Trt)-OH following Gly29 was ineffective.

Pseudoproline-containing building blocks were subsequently introduced at selected positions to help reduce aggregation during peptide elongation. Combined with HMPB-ChemMatrix resin chemistry, the optimized strategy produced the linear pediocin precursor with approximately 70–80% crude purity after cleavage and side-chain deprotection.
This case illustrates an important principle in difficult peptide synthesis: locating the region where chain assembly begins to deteriorate can be more useful than globally applying stronger conditions to the entire sequence.
Practical Strategies for Difficult Peptides
Once the problematic region is identified, synthesis conditions can be adjusted more selectively. Depending on the sequence, useful approaches may include lower resin loading, PEG-containing resins, double coupling at selected positions, alternative coupling reagents, optimized solvent systems and carefully controlled temperature.
For aggregation-prone sequences, pseudoproline, backbone-protection and depsipeptide strategies can temporarily disrupt backbone interactions and improve accessibility of the growing chain. The objective is not simply to increase reaction strength, but to address the physical or chemical reason that a particular region is difficult to synthesize.
Crude HPLC and LC-MS are therefore useful not only as final quality-control methods but also as tools for understanding synthesis performance. Improving crude quality generally creates a more favorable starting point for downstream peptide purification by RP-HPLC.
Conclusion
Many SPPS failures are chemically understandable. Aggregation can restrict reagent accessibility, incomplete reactions can produce deletion sequences, and sensitive residues may undergo racemization or aspartimide formation. Effective troubleshooting therefore depends on understanding where the synthesis becomes difficult and what chemical or physical factor is responsible.
For an introduction to the complete synthesis process, see Solid-Phase Peptide Synthesis (SPPS): A Practical Guide. Alan Scientific also provides custom peptide synthesis for difficult, long, modified and non-standard peptide sequences.
References
1. Coin I, Beyermann M, Bienert M. Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences.Nature Protocols. 2007;2:3247–3256. doi:10.1038/nprot.2007.454.
2. Krchnák V, Flegelová Z, Vágner J. Aggregation of resin-bound peptides during solid-phase peptide synthesis: prediction of difficult sequences.International Journal of Peptide and Protein Research. 1993;42(5):450–454. doi:10.1111/j.1399-3011.1993.tb00153.x.
3. Tickler AK, Wade JD. Overview of solid phase synthesis of difficult peptide sequences.Current Protocols in Protein Science. 2007;Chapter 18:Unit 18.8. doi:10.1002/0471140864.ps1808s50.
4. Bédard F, Hammami R, Zirah S, Rebuffat S, Fliss I, Biron E, et al. Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.Scientific Reports. 2018;8:9029. doi:10.1038/s41598-018-27225-3.